Axogen (AXGN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.12
- EPS estimate
- $0.12
- EPS surprise
- −1.15%
- Revenue surprise
- +3.92%
- Revenue
- $69.7M
- Revenue estimate
- $67.1M
- Reported
- Jul 29, 2026
Axogen reported Q2 2026 results on July 29, 2026. Earnings per share were $0.12, matching the $0.12 estimate in rounded terms, a 1.15% miss on the unrounded figure. Revenue was $69.7 million, ahead of the $67.1 million consensus by 3.92%. Compared with Q2 2025, EPS was unchanged at $0.12, while revenue rose about 23% from $56.7 million.
Annual results were losses of $0.30 per share in 2022 and $0.18 in 2023, followed by profits of $0.13 in 2024 and $0.29 in 2025. Revenue grew every year, from $138.7 million in 2022 to $225.3 million in 2025, about 62% higher. The first half of 2026 adds up to $0.19 per share, against $0.10 a year earlier, on revenue about 25% higher. Q2 2026 set the revenue high in the table, and the $0.12 per share ties the EPS high. Over the last 20 quarters, Axogen beat the EPS estimate 15 times, though the three most recent quarters were misses.
Q3 results came between October 29 and November 8 in each of the past five years. That points to late October or early November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 29, 2026 | $0.12 | $0.12 | −1.15% | $69.7M | SEC |
| Q1 2026 | Apr 28, 2026 | $0.08 | $0.07 | −6.67% | $61.5M | SEC |
| Q4 2025 | Feb 24, 2026 | $0.09 | $0.07 | −22.22% | $59.9M | SEC |
| Q3 2025 | Oct 29, 2025 | $0.07 | $0.12 | +66.20% | $60.1M | SEC |
| Q2 2025 | Aug 5, 2025 | $0.06 | $0.12 | +88.68% | $56.7M | SEC |
| Q1 2025 | May 8, 2025 | $0.01 | −$0.02 | −236.99% | $48.6M | SEC |
| Q4 2024 | Feb 25, 2025 | $0.04 | $0.07 | +96.63% | $49.4M | SEC |
| Q3 2024 | Nov 7, 2024 | $0.01 | $0.07 | +1066.67% | $48.6M | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.06 | $0.05 | +178.13% | $47.9M | SEC |
| Q1 2024 | May 2, 2024 | −$0.07 | −$0.06 | +11.76% | $41.4M | SEC |
| Q4 2023 | Mar 5, 2024 | −$0.07 | −$0.06 | +16.08% | $42.9M | SEC |
| Q3 2023 | Nov 7, 2023 | −$0.06 | $0.01 | +115.63% | $41.3M | SEC |
| Q2 2023 | Aug 7, 2023 | −$0.12 | −$0.03 | +75.25% | $38.2M | SEC |
| Q1 2023 | May 9, 2023 | −$0.14 | −$0.10 | +29.58% | $36.7M | SEC |
| Q4 2022 | Mar 14, 2023 | −$0.11 | −$0.03 | +73.50% | $36.2M | SEC |
| Q3 2022 | Nov 8, 2022 | −$0.13 | −$0.01 | +92.06% | $37.0M | SEC |
| Q2 2022 | Aug 3, 2022 | −$0.15 | −$0.06 | +61.11% | $34.5M | SEC |
| Q1 2022 | May 4, 2022 | −$0.15 | −$0.20 | −32.19% | $31.0M | SEC |
| Q4 2021 | Feb 22, 2022 | −$0.13 | −$0.08 | +39.16% | $31.5M | SEC |
| Q3 2021 | Nov 3, 2021 | −$0.13 | −$0.09 | +28.97% | $31.2M | SEC |
Quarterly revenue
Frequently asked questions
When did Axogen (AXGN) last report earnings?
Axogen last reported on Jul 29, 2026, covering fiscal Q2 2026.
Did AXGN beat earnings estimates?
No. Axogen reported EPS of $0.12 for Q2 2026 against a $0.12 estimate — a 1.15% miss.
How much revenue did AXGN report last quarter?
Axogen reported $69.7M in revenue for Q2 2026, against a consensus estimate of $67.1M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.